Samara Rosenfeld

The incidence rate of serious infection events and opportunistic infections was higher among the upadacitinib 30 mg group than the 15 mg group.

The findings are based on data from a 24-week observation from an ongoing phase 3 PATERA study.

Patients report sustained improvements in pain and fatigue from taking ixekizumab every 2 or 4 weeks over 3 years.

The findings are important to understand treatment persistence and switch patterns in rheumatoid arthritis patients with poor prognostic factors in a real-world setting.

Findings suggest 5-10 mg of tanezumab significantly improve pain versus placebo in patients with chronic low back pain.

The results highlight a significant improvement in rheumatoid arthritis signs and symptoms for those who used upadacitinib over placebo and adalimumab.

Patients are unaffected by the switch from ADL-EU to ADL-PF.

Other treatment plans need to be considered for women with anxiety or insomnia.

Rituximab should be the gold-standard treatment.

Guidelines are needed to better understand who needs the test.

Healthcare professionals can use technology to promote, educate, and support women who breastfeed.

Younger patients with sickle cell disease report more positive experiences in the emergency department than older patients.

This is the first non-surgical option approved by the FDA to treat fibroid-related heavy menstrual bleeding.

EHRs have only modestly increased their safety during a 10-year period, leaving critical deficiencies.

Healthcare experts can intervene earlier to help lessen the overall effects of concussion over time.

Historically, representation of women and minority populations is low in surgical specialties.

The findings can lead physicians to stop prescribing the drug.

A new study shows that biomechanical footwear improved osteoarthritis knee pain at 24 weeks as compared to patients in a control group who wore traditional footwear. The results, although statistically significant, need to be replicated to prove clinical importance, researchers reported in JAMA.

Pregnant women who took fluconazole orally had a higher risk of giving birth to a baby with muscle and bone malformation, shows a new study published in The BMJ.

Medications can help, especially in situations where weight gain can occur at a rapid rate.

The findings emphasize the need to have a healthy diet and lifestyle before pregnancy.

The intervention is effective, feasible, and acceptable among patients with hypertension.

Understanding and addressing clinician burnout need to be prioritized at a system and local level.

Taking oral fluconazole in the first trimester is not associated with oral clefts or conotruncal malformations.

There is a significant and consistent association between pregnancy loss and later type 2 diabetes.

There is no significant association between biologic exposure and the development of melanoma in patients with IBD, rheumatoid arthritis, or psoriasis.

The findings can lead to early detection and intervention for children with the condition.

Despite proven benefits, there is still a need for more intensive or targeted patient motivational strategies.

Two colleagues from the Lewis Katz School of Medicine discuss the promise of AI to detect diabetic retinopathy.

Patients were more likely to recommend and return to providers who were paternalistic rather than autonomous.